Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Neurosci Lett ; 715: 134547, 2020 01 10.
Article in English | MEDLINE | ID: mdl-31629776

ABSTRACT

PURPOSE: To evaluate the local nerve myelin recovery and the expression of PSD-95 protein and mRNA in the L4-L6 segment of the spinal cord after applying Brazilein to sciatic nerve injury BALB/c mice model and investigate the regulatory effects of Brazilein on myelin recovery after peripheral nerve injury. METHODS: A total of 160 BALB/c mice were selected to establish the unilateral sciatic nerve injury model and randomly divided into four groups: saline blank control, Brazilein high-dose, medium-dose, and low-dose. Mice were assessed at different time points (1 w, 2 w, 4 w, 8 w) after sciatic nerve injury for the sciatic functional index (SFI) and sciatic nerve function recovery of the injured side by myelin Luxol Fast Blue (LFB) staining of the sciatic nerve. In addition, immunohistochemistry, real time-PCR, and Western blot were used to detect the PSD-95 expression in the spinal cord L4-L6 segments of the injured sciatic nerve at each time point. RESULTS: The results of SFI and sciatic nerve function recovery, as well as, myelin LFB staining of the injured side indicated that all indexes of the Brazilein middle- and high-dose groups were significantly better than the low-dose and blank control groups at each time point. The PSD-95 expression in the L4-L6 segment of the spinal cord was statistically lower in the high- and medium-dose groups than in the low-dose and blank control groups at 1 w, 2 w, and 4 w, while the differences between the groups were not significant at 8 w. CONCLUSION: Brazilein inhibits PSD-95 activation in the corresponding segment of sciatic nerve spinal cord in BALB/c mice after sciatic nerve injury, thereby inhibiting the excessive expression of free radicals and promoting myelin regeneration.


Subject(s)
Benzopyrans/therapeutic use , Disks Large Homolog 4 Protein/antagonists & inhibitors , Disks Large Homolog 4 Protein/biosynthesis , Indenes/therapeutic use , Recovery of Function/physiology , Sciatic Neuropathy/drug therapy , Sciatic Neuropathy/metabolism , Animals , Benzopyrans/pharmacology , Disks Large Homolog 4 Protein/genetics , Gene Expression , Indenes/pharmacology , Male , Mice , Mice, Inbred BALB C , Nerve Regeneration/drug effects , Nerve Regeneration/physiology , Peripheral Nerve Injuries/drug therapy , Peripheral Nerve Injuries/metabolism , Recovery of Function/drug effects , Sciatic Nerve/drug effects , Sciatic Nerve/injuries , Sciatic Nerve/metabolism , Sciatic Neuropathy/genetics , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL